Question 1

What is the gender health gap and how much does it cost?

Accepted Answer

The gender health gap is the systematic disparity in healthcare quality, research funding, and clinical outcomes between men and women. Women wait 4 years longer for diagnosis on average, are underrepresented in 80% of clinical trials, and are 50% more likely to be misdiagnosed after a heart attack. The McKinsey Global Institute estimates this gap costs the global economy $1 trillion annually. ORI quantifies these gaps with 115+ clinical intelligence tools.

Question 2

How long does it take to diagnose endometriosis?

Accepted Answer

The average time to diagnose endometriosis is 7.5 years from symptom onset. During this diagnostic odyssey, patients see an average of 7 different physicians, accumulate $15,000-$100,000+ in medical costs, and frequently receive misdiagnoses including IBS, anxiety, or 'normal period pain.' ORI's Diagnostic Odyssey Decoder maps these journeys and identifies where diagnostic shortcuts can reduce both time and cost.

Question 3

Are drug doses different for women?

Accepted Answer

Yes, many drugs require different doses for women. Women metabolize drugs differently due to higher CYP3A4 enzyme activity (20-40% more active), different body composition (higher fat percentage affects drug distribution), and hormonal fluctuations across the menstrual cycle. The most notable example: the FDA mandated a 50% dose reduction of zolpidem (Ambien) for women in 2013 after data showed dangerous next-morning impairment. ORI's dosing database covers 40+ drugs with female-specific recommendations backed by PubMed citations.

Question 4

How much does menopause cost employers?

Accepted Answer

Menopause costs employers approximately $4.2 million per year for a 1,000-employee company with 52% female workforce. This breaks down to: absenteeism (11 extra sick days/year per affected employee), presenteeism (30-40% productivity reduction on symptomatic days), and turnover (1 in 4 women consider leaving work due to menopause symptoms, with $52,000 average replacement cost). ORI's Workforce Impact Simulator provides company-specific calculations.

Question 5

What is PCOS and how is it diagnosed?

Accepted Answer

PCOS (Polycystic Ovary Syndrome) affects 8-13% of women of reproductive age and is diagnosed using the Rotterdam criteria, which requires 2 of 3 features: irregular periods (oligoovulation), clinical or biochemical hyperandrogenism (excess male hormones), and polycystic ovarian morphology on ultrasound. There are 4 phenotypes (A through D) with different clinical profiles and treatment approaches. ORI's Phenotype Stratifier classifies PCOS subtype and provides evidence-based management recommendations.

Question 6

What is the pension gap from caregiving?

Accepted Answer

Women perform 75% of unpaid caregiving globally, creating a significant pension gap. In the US, 5 years out of the workforce for caregiving results in approximately $143,000 in lost lifetime retirement income from reduced Social Security contributions and missed employer 401(k) matches. In Switzerland, the gap can exceed CHF 200,000 due to the BVG/LPP occupational pension structure. ORI calculates country-specific pension gaps for the US, UK, Switzerland, Sweden, Denmark, Norway, and Finland.

Question 7

How can AI help with women's health?

Accepted Answer

AI can help close the gender health gap by providing sex-specific clinical intelligence at scale. ORI is an MCP (Model Context Protocol) server with 115+ tools that AI assistants can use to: verify drug doses for women (40+ drugs with FDA mandates), interpret health data within menstrual cycle context, match patients to clinical trials, detect diagnostic odyssey patterns, audit clinical trials for sex bias, and quantify the economic burden of women's health gaps for employers, payers, and policy makers.

Question 8

What is sex bias in clinical trials?

Accepted Answer

Sex bias in clinical trials refers to the systematic underrepresentation or exclusion of women from medical research. Despite FDA guidance requiring sex-balanced enrollment, many trials still enroll predominantly male participants. This leads to drugs being approved based primarily on male physiology, missing sex-specific adverse effects and optimal dosing. ORI's Sex Bias Audit Engine analyzes trial protocols for enrollment ratio bias, endpoint selection bias, and provides composite bias scores with recommendations for improving sex equity in research.

Question 9

What is a diagnostic odyssey in healthcare?

Accepted Answer

A diagnostic odyssey is the prolonged, often years-long journey patients undergo before receiving a correct diagnosis. It disproportionately affects women's health conditions: endometriosis (7.5 years average), PCOS (2-4 years), autoimmune diseases (4.5 years), and rare diseases (5-7 years). During this period, patients accumulate $15,000-$100,000+ in costs from repeated specialist visits, unnecessary tests, and misdiagnoses. ORI's Diagnostic Odyssey Decoder maps optimal vs actual diagnostic pathways and quantifies the cost of delays.

Question 10

How does HRV change during the menstrual cycle?

Accepted Answer

Heart Rate Variability (HRV) naturally fluctuates across the menstrual cycle. During the follicular phase (days 1-14), HRV tends to be higher as parasympathetic tone dominates. Around ovulation, HRV may briefly spike. In the luteal phase (days 15-28), HRV typically drops 10-15% as progesterone increases sympathetic nervous system activity. Resting heart rate also increases 2-5 BPM around ovulation. ORI's Cycle Intelligence Engine contextualizes HRV readings within cycle phase, preventing false health alarms from normal hormonal variations.